Europe Clinical Nutrition Market Size

Europe Clinical Nutrition Market Analysis

The Europe Clinical Nutrition Market size is estimated at USD 21.02 billion in 2024, and is expected to reach USD 31.39 billion by 2029, growing at a CAGR of 8.35% during the forecast period (2024-2029).

COVID-19 infection became a major public health concern, and clinical nutrition played a crucial role in preventing infection and treating infection-associated malnutrition. Major micronutrients such as vitamins A, B6, B12, folate, C, D, and E and trace elements (Zinc, Selenium, and Copper) are known to play important roles in regulating both innate and adaptive immune responses, which were essential to maintaining during COVID-19. Further, according to the article published by researchers in Europe in December 2022 in the Clinical Nutrition journal, COVID-19 significantly induced severe alterations in the patient's nutritional status, which notably impacted the clinical outcomes. Due to this, the adoption of clinical nutrition products was significantly high during the pandemic, which positively impacted the growth of the studied market over the forecast period. In the current scenario, the market is experiencing its pre-pandemic trends due to the increase in demand for clinical nutrition products as COVID-19-related restrictions have been eased.

The major factors attributing to the growth of the market are the increasing prevalence of metabolic disorders and high spending on healthcare. For instance, according to the 2022 statistics published by the International Diabetes Federation (IDF) Diabetes Atlas, 3.94 million people were diagnosed with diabetes in France in 2021. This number is expected to rise to 4.18 million by 2030 and 4.22 million by 2040 in France. Thus, the increasing burden of diabetes in the region is expected to increase the demand for clinical nutrition, thereby boosting the market growth.

Furthermore, the increasing government initiatives in launching guidelines and aware people regarding clinical nutrition are also contributing to the growth of the market. For instance, in November 2022, German hospitals and nursing homes took part in the new nDay campaign launched by the German Federal Ministry of Food and Agriculture (BMEL) in cooperation with the Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, the German Clinical Nutrition Society (DGEM), and the German Nutrition Society (DGE) to support nationwide participation in the nutritionDay audit (nDay). The campaign provided current data on the prevalence of malnutrition as well as existing care structures in hospitals and nursing homes in Germany. Similarly, in January 2022, World Health Organization/Europe launched a new, voluntary, Member State-led Sugar and Calorie Reduction Network to promote healthier diets as well as reduce overweight and obesity levels across the World Health Organization European Region.

Furthermore, the presence of key market players and their strategic activities, like product launches, agreements, and collaboration to increase product availability in Europe, is further expected to bolster market growth over the forecast period. For instance, in April 2022, Glanbia Nutritionals launched TechVantage at the nutraceutical event Vitafoods Europe. TechVantage will provide customers with nutrient solutions with stability enhancements, the ability to mask flavors/colors, and solubility/flowability improvements. Similarly, in November 2022, Dairy Cooperative Laïta Nutrition launched DADFMS, a powder-based nutritional solution based on dairy proteins, which effectively meets the needs of patients suffering from or at risk of malnutrition (FSMPs). Laïta Nutrition developed this prepacked powder because many pathologies hinder patient autonomy and are associated with swallowing disorders, often leading to the long-term deterioration of nutritional status.

However, imprecise perceptions about clinical nutrition are likely to restrain the market growth over the forecast period.